Saúde Pública/Medicina Humanitária
Dados europeus sobre a variante Ômicron: dos 109 casos confirmados até agora, todos sobre os quais há informação disponível quanto à gravidade foram assintomáticos ou leves.
6 Dez, 2021 | 16:22h
Comentário no Twitter:
EUROPEAN EQUIVALENT OF CDC AS OF THIS AM: "All cases [of Omicron] for which there is available information on severity were either asymptomatic or mild. No deaths have been reported among these cases so far.". But let's keep on watching. https://t.co/3jHm4Wezi8
— Monica Gandhi MD, MPH (@MonicaGandhi9) December 3, 2021
OMS ainda não tem relatos sobre mortes por Covid causadas pela variante Ômicron.
6 Dez, 2021 | 16:21hWHO has no reports yet of Omicron Covid deaths – MedicalXpress
Comentário no Twitter
Despite #OmnicronVariant's global spread, the WHO says there are no Omicron deaths so far. The agency warns it may take weeks to determine how infectious the variant is, whether it causes more severe illness & how effective antivirals & vaccines are https://t.co/NSN6Ysf3gc pic.twitter.com/Wnp90HvUng
— delthia ricks 🔬 (@DelthiaRicks) December 4, 2021
Fauci afirma que os relatórios preliminares sobre a variante Ômicron são encorajadores – “Até o momento, não parece haver um alto nível de gravidade.”
6 Dez, 2021 | 16:19hFauci says Omicron variant doesn’t look severe, but ‘got to be careful’ – Associated Press
Editorial | O surgimento da nova variante de preocupação Ômicron (B.1.1.529) do SARS-CoV-2 destaca a capacidade de pesquisa da África, mas expõe as principais lacunas do conhecimento, as inequidades na distribuição de vacinas e as inadequações na resposta global à COVID-19 e nos esforços para controle.
6 Dez, 2021 | 16:17hO impacto global do câncer em adolescentes e jovens adultos em 2019: análise sistemática para o Global Burden of Disease Study 2019.
6 Dez, 2021 | 16:02hComentário convidado: Burden of cancer in adolescents and young adults – The Lancet Oncology
[Preprint] Dados preliminares apontam para risco aumentado de reinfecção pelo SARS-CoV-2 associado com o surgimento da variante Ômicron na África do Sul.
3 Dez, 2021 | 11:16hComentários:
Global Omicron COVID cases rise as evidence for immune escape grows – CIDRAP
Omicron seems to carry higher Covid reinfection risk, says South Africa – The Guardian
Reinfections three times more likely with Omicron: S. African research – MedicalXpress
Comentário da autora no Twitter (fio – clique para saber mais)
[Thread] We have updated our preprint on SARS-CoV-2 reinfection trends in South Africa to include data through late November. @hivepi @jd_mathbio @carivs @Dr_Groome @nicd_sa #SACEMAhttps://t.co/yvIRtfQH6I#notyetpeerreviewed https://t.co/EKr8fgJVba
— Juliet Pulliam, PhD (@SACEMAdirector) December 2, 2021
Variante Ômicron do SARS-CoV-2: um novo capítulo na pandemia de COVID-19.
3 Dez, 2021 | 11:14hOmicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic – The Lancet
Comentário no Twitter
NEW—Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
In a Comment, @ProfAbdoolKarim provides preliminary indications on transmissibility, severity, and immune escape from what is known about #Omicron's mutations. https://t.co/fWJq2ZSlNK pic.twitter.com/ijpgirZ5wj
— The Lancet (@TheLancet) December 2, 2021
Infográfico interativo | Visualização das vias de transmissão do SARS-CoV-2 e mitigações.
3 Dez, 2021 | 11:13hVisualising SARS-CoV-2 transmission routes and mitigations – The BMJ
Comentário: New interactive graphic tool illustrates SARS-CoV-2 transmission routes and mitigations – News Medical
Comentário no Twitter
Is it risky to sing in a choir or eat in a small restaurant? How much difference does it make if I open windows or clean surfaces?
A new #BMJInfographic helps people decide what to do in everyday situations to protect themselves, and others, from covid-19 https://t.co/RMoEwZ9wTz pic.twitter.com/XV9ElCoOGa
— The BMJ (@bmj_latest) December 2, 2021
Coleção | O que o mundo pode aprender com a resposta da China à Covid-19?
3 Dez, 2021 | 11:11hPágina principal: China’s response to Covid-19 – The BMJ
Editorial: What can the world learn from China’s response to covid-19?
Importance of public health tools in emerging infectious diseases
Non-pharmaceutical interventions during the roll out of covid-19 vaccines
Use of contact tracing, isolation, and mass testing to control transmission of covid-19 in China
Role of asymptomatic and pre-symptomatic infections in covid-19 pandemic
Effectiveness of 14 day quarantine strategy: Chinese experience of prevention and control
Cold chain logistics: a possible mode of SARS-CoV-2 transmission?
Better modelling of infectious diseases: lessons from covid-19 in China
Learning for the next pandemic: the Wuhan experience of managing critically ill people
Podcast | A variante Ômicron do SARS-CoV-2.
3 Dez, 2021 | 11:10hThe Omicron Variant of SARS-CoV-2 – New England Journal of Medicine


